Nevertheless, one-quarter of participants had baseline CD4 counts <200 cells/μL; therefore, efforts to identify and link people to ART early in the disease course remain essential, along with screening and prophylaxis for cryptococcal disease and TB and diagnosis and treatment of severe bacterial infections. This evidence concerns the gene CD4 and tuberculosis.